Skip to main content

Male Infertility

2
Pipeline Programs
11
Companies
10
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Dexa Medica
Dexa MedicaIndonesia - Tangerang
1 program
1
DLBS5055 200mgPhase 41 trial
Active Trials
NCT06100432Active Not Recruiting90Est. Oct 2025
Medica Corp
Medica CorpMA - Bedford
1 program
1
DLBS5055 200mgPhase 4
Human BioSciences
Human BioSciencesWV - Martinsburg
4 programs
Genetic Causes of Male InfertilityN/A1 trial
Identifying Molecular Determinants of Infertility in Men (MODIFY)N/A1 trial
Regulation of Stem Spermatogonia in the Mature TestisN/A1 trial
Small RNA Pathways in Mammalian GametogenesisN/A1 trial
Active Trials
NCT00341120Completed400Est. Aug 2012
NCT06147700Completed100Est. Jun 2024
NCT02756923Completed142Est. Dec 2019
+1 more trials
Q Therapeutics
Q TherapeuticsUT - Salt Lake City
1 program
AndrofertiN/A1 trial
Active Trials
NCT03466229CompletedEst. Dec 2016
Innovation Pharmaceuticals
1 program
Density Gradient CentrifugationN/A1 trial
Active Trials
NCT06545318Completed115Est. Nov 2023
Aytu BioPharma
Aytu BioPharmaDENVER, CO
1 program
DiagnosticN/A1 trial
Active Trials
NCT02839447Withdrawn0Est. Apr 2026
Biocorp
BiocorpFrance - Issoire
1 program
ProbioticsN/A1 trial
Active Trials
NCT07345455Recruiting60Est. Dec 2026
Labcorp
LabcorpBURLINGTON, NC
1 program
SpermotrendN/A1 trial
Active Trials
NCT04256278Completed80Est. Apr 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Dexa MedicaDLBS5055 200mg
Aytu BioPharmaDiagnostic
Human BioSciencesIdentifying Molecular Determinants of Infertility in Men (MODIFY)
BiocorpProbiotics
Innovation PharmaceuticalsDensity Gradient Centrifugation
LabcorpSpermotrend
Q TherapeuticsAndroferti
Human BioSciencesSmall RNA Pathways in Mammalian Gametogenesis
Human BioSciencesRegulation of Stem Spermatogonia in the Mature Testis
Human BioSciencesGenetic Causes of Male Infertility

Clinical Trials (10)

Total enrollment: 1,169 patients across 10 trials

Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ β-carotene) for Infertile Males

Start: Nov 2023Est. completion: Oct 202590 patients
Phase 4Active Not Recruiting

A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0

Start: Sep 2025Est. completion: Apr 20260
N/AWithdrawn
NCT06147700Human BioSciencesIdentifying Molecular Determinants of Infertility in Men (MODIFY)

Identifying Molecular Determinants of Infertility in Men (MODIFY)

Start: Oct 2023Est. completion: Jun 2024100 patients
N/ACompleted

Probiotics on Sperm Quality in Male Infertility Patients

Start: Sep 2023Est. completion: Dec 202660 patients
N/ARecruiting
NCT06545318Innovation PharmaceuticalsDensity Gradient Centrifugation

A Novel Sperm Selection Method Provides Advantages Over Conventional Approaches

Start: Jan 2023Est. completion: Nov 2023115 patients
N/ACompleted

Administration of Antioxidants to Infertile Men and Sperm Quality

Start: Feb 2020Est. completion: Apr 202280 patients
N/ACompleted

Impact of Antioxidant Treatment on DNA Fragmentation Index

Start: Jul 2015Est. completion: Dec 2016
N/ACompleted
NCT02864329Human BioSciencesSmall RNA Pathways in Mammalian Gametogenesis

Small RNA Pathways in Mammalian Gametogenesis

Start: Apr 2014Est. completion: Mar 2024182 patients
N/ACompleted
NCT02756923Human BioSciencesRegulation of Stem Spermatogonia in the Mature Testis

Regulation of Stem Spermatogonia in the Mature Testis

Start: Apr 2012Est. completion: Dec 2019142 patients
N/ACompleted
NCT00341120Human BioSciencesGenetic Causes of Male Infertility

Genetic Causes of Male Infertility

Start: Jan 2003Est. completion: Aug 2012400 patients
N/ACompleted

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 1,169 patients
11 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.